Media
Webcast Abstracts
MDO Webinars
Title: Min-Vasive Medtech Webinar Series
Date: August 18-20, 2026
Abstract:
The MDO Min-Vasive Medtech virtual series features device engineers and designers from major OEMs and groundbreaking startups that are developing minimally invasive medical technology.
The latest wave of minimally invasive technologies — such as robotics systems, catheter-delivered therapies, neurotech, miniaturized devices and next-generation implants — can reduce procedure complications, shorten recovery times and cut costs.
We’ll discuss minimally invasive device development and the cutting-edge advances in medtech materials, components and manufacturing that make them possible. We’ll also take questions from our live audience in a Q&A session to conclude each interview.
These webinars will also be available for on-demand replay shortly after they air.
Title: Drug Delivery/Diabetes
Date: April 9, 2026
Abstract:
From increasingly miniaturized continuous glucose monitors to automated insulin delivery, medtech is transforming the way people treat type 1 diabetes — and the technologies are increasingly branching into the treatment of type 2 diabetes.
Join us as we host experts from a major diabetes treatment tech OEM who will describe some of the latest advances, the technologies enabling them, and what’s next. We’ll make room for a Q&A at the end. This webinar will be available for on-demand replay shortly after it airs.
Title: Nitinol Knowledge
Date: May 14, 2026
Abstract:
Nitinol might be the most exciting material in medtech, finding use in minimally invasive procedures and cutting-edge systems such as cardiac ablation catheters and implants, surgical robotics, thrombectomy and revascularization devices, brain implants and more.
We’ll host a nitinol expert within a major OEM or groundbreaking startup to explain how they use nitinol’s special properties for innovative devices and procedures, discuss challenges in designing and manufacturing with nitinol, and offer questions medtech developers should ask when vetting and working with nitinol partners.
We’ll also save time at the end of this live interview for questions from our virtual audience. This webinar will be available for on-demand replay shortly after it airs.Our 2025 Nitinol Knowledge webinar featured retired Edwards Lifesciences Engineering SVP Ming Wu. Suggestions for future speakers are welcomed by MDO Managing Editor Jim Hammerand.
Title: Medtech Big 100 Movers
Date: September 24, 2026
Abstract:
The Medtech Big 100 is the definitive ranking of the world’s largest medical device developers and manufacturers by revenue and analysis of industry trends. We present this flagship project online, in our annual Big 100 issue of Medical Design & Outsourcing magazine, and a special report with additional metrics such as employment and R&D spending, plus a notable highlights and notes about every company on our list, as well as some who just barely missed the cut.
We anticipate a big change coming at the top of our list with Johnson & Johnson MedTech poised to overtake Medtronic as the world’s largest medtech company. Our Medtech Big 100 Movers webinar will feature a roundtable discussion with the MDO editors behind this project: Editor in Chief Chris Newmarker, Managing Editor Jim Hammerand and Senior Editor Danielle Kirsh.
They’ll offer their analysis and commentary on the project’s findings and what they’ll be watching for in the months and years ahead. This webinar may also feature a special guest or two from the medtech industry to share their perspective on major challenges, opportunities and strategies for both.
We’ll also take live questions from our virtual audience throughout the presentation and offer a preview of the MDO team’s plans for the year ahead. This webinar will be available for on-demand replay shortly after it airs.
DeviceTalks Webinars
Title: Cardiac Innovations Series
Date: February 3-5, 2026
Abstract:
The DeviceTalks Cardiac Innovations virtual series takes an in-depth look at the technologies driving the next generation of cardiovascular care. Hosted by the DeviceTalks editorial team, the series features daily interviews with leaders from global OEMs, mid-sized MedTechs, and disruptive startups developing novel therapies for a wide range of cardiac conditions.
Innovations across cardiac care—including transcatheter valve interventions, mechanical circulatory support, cardiac rhythm management, and minimally invasive heart failure therapies—are transforming how clinicians treat patients with structural, electrical, and functional heart disease. These advancements reduce procedural risk, expand access to treatment, and improve both short- and long-term outcomes. Each session concludes with a live Q&A, giving attendees a chance to engage directly with MedTech’s cardiac leaders.
Title: Surgical Robotics Series
Date: April 14-16, 2026
Abstract:
The DeviceTalks Surgical Robotics virtual series explores how robotics is reshaping the modern operating room. Hosted over multiple days by the DeviceTalks editorial team, this series features conversations with the leaders building the next generation of surgical systems—from established OEMs refining legacy platforms to startups introducing nimble, modular alternatives.
Today’s platforms are delivering smaller incisions, improved ergonomics, and standardized outcomes, augmented by AI-guided navigation, real-time visualization, and emerging remote capabilities. These technologies are rapidly expanding across specialties, from orthopedics and soft-tissue to neuro and dental procedures.
We’ll examine the challenges and opportunities of making robotic surgery more scalable and accessible. Live interviews and interactive Q&As offer a behind-the-scenes look into how these platforms are built—and where they’re headed next.
Title: NeuroTech Series
Date: June 9-11, 2026
Abstract:
The DeviceTalks NeuroTech virtual series brings together the intersection of neuroscience, bioelectronics, and digital therapeutics. Throughout this week-long series, the DeviceTalks editorial team will spotlight companies developing life-changing solutions for conditions like epilepsy, Parkinson’s, depression, stroke, and chronic pain.
Neurotechnology is reshaping treatment paradigms through innovations in neurostimulation, closed-loop systems, minimally invasive brain implants, and brain-computer interfaces (BCIs). These technologies not only restore function, but unlock new modes of communication and cognitive support. As this field expands, it raises questions around usability, power management, clinical validation, and ethical deployment.
Each session will feature live conversations with leaders developing the tools to decode, modulate, and support the human nervous system — with live Q&A and on-demand access for those who can’t attend in real time.
Title: Interventional Innovations Series
Date: July 28-30, 2026
Abstract:
The DeviceTalks Interventional Innovations series explores how next-gen technologies are transforming catheter-based procedures across cardiovascular, peripheral, and oncologic specialties.
Hosted by the DeviceTalks team, this multi-day series will explore tools like intravascular lithotripsy, embolic protection devices, microcatheters, drug-coated balloons, and smart guidewires — many of which are pushing interventional procedures toward safer, faster, and more data-driven outcomes.
Each day’s conversation includes a live Q&A with the presenting team and is available to stream on-demand for registrants who prefer flexible viewing.
Title: Connected Health Series
Date: October 8-10, 2026
Abstract:
The DeviceTalks Connected Health virtual series highlights the technologies and strategies that connect patients, devices, and care teams in real-time. Join the DeviceTalks editorial team for a full week of conversations with the developers building secure, scalable, and clinically meaningful digital health ecosystems.
Connected health includes everything from wearable biosensors, remote patient monitoring systems, and connected implants to data analytics platforms, mobile health apps, and AI-supported triage tools. These tools can improve outcomes by enabling proactive care, reducing hospital visits, and generating new insights for clinical decision-making.
This series will examine how device developers are tackling the regulatory, technical, and business challenges of connectivity — while creating products that seamlessly integrate into clinicians’ and patients’ lives. Each session includes live Q&A and full access to on-demand replays for continued viewing.
Title: Orthopedic Technologies Series
Date: November 10-12, 2026
Abstract:
The DeviceTalks Orthopedics virtual series brings together the developers, surgeons, and commercial teams who are reinventing musculoskeletal care through precision technologies and smarter implants.
The field is evolving fast. With advances in robotic-assisted surgeries, smart implants, patient-specific planning, bone regeneration technologies, and intraoperative imaging, orthopedic companies are finding new ways to improve accuracy, extend implant life, and accelerate recovery. Emerging solutions like AI-driven surgical navigation and 3D-printed implants are expanding what’s possible in the OR.
Over the full week, the DeviceTalks editorial team will explore how these technologies are being developed, tested, and brought to market. Each session includes an interview with a key player in the orthopedic device ecosystem, followed by a live Q&A and on-demand access.